United States:
Coming Soon: Paradigm Shift In Genetic Resources Regs
02 November 2013
WilmerHale
To print this article, all you need is to be registered or login on Mondaq.com.
It has been 20 years in the making, but a new regulatory scheme
is quickly moving into force. This emerging regime may impact the
development of, and intellectual property rights surrounding, an
array of products, including pharmaceuticals, biotech products,
agricultural products, nutritionals, supplements, cosmetics,
perfumes and fragrances and industrial enzymes.
Please click here to view the full text of this
article.
Originally published on Law360, New York (October 28,
2013)
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
USPTO Embraces AI Tools In New Guidance
Crowell & Moring LLP
On April 11, 2024, the USPTO published its "Guidance on Use of Artificial Intelligence-Based Tools in Practice Before the United States" in the Federal Register (the "Guidance"). As the title suggests...
Breaking Down The EPO's Revised Practice Guidelines
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The guidelines for examination in the European Patent Office instruct on the practice and procedure related to the examination of European patent applications...
USPTO Issues Guidance On Use Of AI-Based Tools
Greenberg Traurig, LLP
On April 11, 2024, the U.S. Patent and Trademark Office (USPTO) issued Guidance on Use of Artificial-Intelligence-Based Tools (Guidance), which applies existing rules and policies...